Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: ANZU) is a medical device company focused on fully implantable hearing solutions, including its Esteem device and its Acclaim cochlear implant system. The company completed its de-SPAC merger with Anzu Special Acquisition Corp I, sponsored by Anzu Partners, a deep-tech venture firm, with the combined entity beginning to trade in 2023 following the SPAC's 2021 IPO. Operating in the medical devices and hearing health sector, Envoy Medical filed its 10-Q for the period ended June 30, 2023, with the SEC on August 14, 2023, reflecting its early quarters as a newly public company. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time data on ANZU and hundreds of other SPAC transactions.